Total Payments
$104,307
2024 Payments
$9,328
Companies
50
Transactions
1,002
Medicare Patients
19,104
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$76,518 (73.4%)
Food & Beverage$22,465 (21.5%)
Travel$4,677 (4.5%)
Consulting$634.00 (0.6%)
Education$13.22 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,518 | 37 | 73.4% |
| Food and Beverage | $22,465 | 948 | 21.5% |
| Travel and Lodging | $4,677 | 13 | 4.5% |
| Consulting Fee | $634.00 | 2 | 0.6% |
| Education | $13.22 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $81,493 | 201 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,393 | 61 | $0 (2024) |
| Abbott Laboratories | $4,832 | 73 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,458 | 106 | $0 (2024) |
| Boston Scientific Corporation | $2,289 | 119 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,581 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,186 | 111 | $0 (2024) |
| PFIZER INC. | $561.91 | 38 | $0 (2024) |
| Esperion Therapeutics, Inc. | $407.55 | 30 | $0 (2024) |
| Amgen Inc. | $392.23 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,328 | 129 | Janssen Pharmaceuticals, Inc ($7,006) |
| 2023 | $8,924 | 146 | Janssen Pharmaceuticals, Inc ($5,925) |
| 2022 | $16,373 | 118 | Janssen Pharmaceuticals, Inc ($14,206) |
| 2021 | $13,195 | 139 | Janssen Pharmaceuticals, Inc ($10,547) |
| 2020 | $8,623 | 98 | Janssen Pharmaceuticals, Inc ($6,847) |
| 2019 | $13,502 | 87 | Janssen Pharmaceuticals, Inc ($12,526) |
| 2018 | $13,126 | 114 | Janssen Pharmaceuticals, Inc ($10,782) |
| 2017 | $21,236 | 171 | Janssen Pharmaceuticals, Inc ($13,652) |
All Payment Transactions
1,002 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: CDS - BG Mini_RM | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: CDS - BG Mini_RM | ||||||
| 12/03/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $61.53 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 11/13/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: CDS - BG Mini_RM | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.50 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: CDS - BG Mini_RM | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 11/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $59.76 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: CDS - BG Mini_RM | ||||||
| 10/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 10/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.00 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/23/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: CDS - BG Mini_RM | ||||||
| 10/15/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 4,870 | 7,929 | $1.6M | $486,265 |
| 2022 | 38 | 5,391 | 9,218 | $1.8M | $557,012 |
| 2021 | 36 | 4,777 | 8,272 | $1.5M | $503,698 |
| 2020 | 28 | 4,066 | 7,033 | $1.3M | $420,326 |
Total Patients
19,104
Total Services
32,452
Medicare Billing
$2.0M
Procedure Codes
144
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 244 | 244 | $292,800 | $93,352 | 31.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 387 | 399 | $359,100 | $62,760 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 521 | 781 | $93,720 | $51,606 | 55.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 195 | 712 | $60,520 | $46,876 | 77.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 304 | 434 | $75,950 | $43,066 | 56.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 156 | 184 | $55,200 | $26,273 | 47.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 126 | 127 | $53,975 | $20,575 | 38.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 108 | 432 | $43,200 | $19,436 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 779 | 1,465 | $80,575 | $15,676 | 19.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 246 | 247 | $17,676 | $13,713 | 77.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 246 | 246 | $59,040 | $12,328 | 20.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 42 | 42 | $41,714 | $10,066 | 24.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 42 | 42 | $29,400 | $8,665 | 29.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 123 | 130 | $117,000 | $7,245 | 6.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $12,825 | $7,123 | 55.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 14 | 548 | $54,800 | $5,003 | 9.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 50 | 50 | $26,988 | $4,727 | 17.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 580 | 695 | $20,850 | $4,671 | 22.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 26 | $9,100 | $4,603 | 50.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 49 | 61 | $9,760 | $3,766 | 38.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 64 | 154 | $15,400 | $3,667 | 23.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 27 | 110 | $11,000 | $3,483 | 31.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 73 | 174 | $13,050 | $3,375 | 25.9% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 47 | 47 | $15,275 | $3,043 | 19.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 16 | 92 | $7,360 | $1,905 | 25.9% |
About Dr. Hani Douedi, MD
Dr. Hani Douedi, MD is a Cardiovascular Disease healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922073949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hani Douedi, MD has received a total of $104,307 in payments from pharmaceutical and medical device companies, with $9,328 received in 2024. These payments were reported across 1,002 transactions from 50 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($76,518).
As a Medicare-enrolled provider, Douedi has provided services to 19,104 Medicare beneficiaries, totaling 32,452 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Toms River, NJ
- Active Since 02/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1922073949
Products in Payments
- XARELTO (Drug) $81,493
- PRADAXA (Drug) $4,569
- WATCHMAN (Device) $1,397
- ELIQUIS (Drug) $1,375
- CAMZYOS (Drug) $959.45
- ENTRESTO (Drug) $916.24
- JARDIANCE (Drug) $824.26
- Quadra Assura CRT Defibrillator (Device) $762.67
- AVEIR (Device) $754.10
- Pacemakers (Device) $725.70
- Confirm Rx (Device) $676.89
- BRILINTA (Drug) $658.95
- FARXIGA (Drug) $633.38
- Allure Quadra RF CRT Pacemaker (Device) $421.00
- NEXLETOL (Drug) $407.55
- Repatha (Biological) $313.30
- LEQVIO (Drug) $269.87
- Assurity Pacemaker (Device) $268.61
- LifeVest (Device) $263.26
- CARDIOFORM Septal Occluder (Device) $239.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Toms River
Dr. Joseph Guarino, M.d, M.D
Cardiovascular Disease — Payments: $20,671
Cardiovascular Disease $20,671
Dr. Kock-Yen Tsang, M.d, M.D
Cardiovascular Disease — Payments: $15,786
Cardiovascular Disease $15,786
John Merlino, Do, DO
Cardiovascular Disease — Payments: $15,000
Cardiovascular Disease $15,000
Dr. Rayson Yang, M.d, M.D
Cardiovascular Disease — Payments: $14,541
Cardiovascular Disease $14,541
Dr. Richard Chang, Do, DO
Cardiovascular Disease — Payments: $10,226
Cardiovascular Disease $10,226
Dr. Victor Bacani, M.d, M.D
Cardiovascular Disease — Payments: $9,419
Cardiovascular Disease $9,419